How Sick is Our Generic Drug Supply?
After my post on the availability of a generic alternative to Bystolic, several readers expressed concern about the quality of generic medications in general. The skeptical cardiologist has posted quite
After my post on the availability of a generic alternative to Bystolic, several readers expressed concern about the quality of generic medications in general. The skeptical cardiologist has posted quite
After revisiting aspirin indications earlier this month I received a few excellent questions that prompted me to delve further into the mysteries of this remarkable anti-platelet drug. First, T.D. Murray
This is my 2018 post updating guidance on aspirin usage in light of the ASPREE trial. It includes a detailed look at the study and was inadvertently deleted as I
A Research Letter in JAMA highlights the lack of price competition in brand name cardiovascular drugs which significantly impacts patient care. “Trends in Within-Class Changes in US Average Wholesale Prices
It has been estimated that patients with paroxysmal atrial fibrillation (PAF) have health care costs 5 times those without afib. More than 50% of those costs are attributed to ER
Old habits die hard in medicine. For decades the skeptical cardiologist and his cardiology brethren and sistren have prescribed aspirin to prevent stroke in patients with atrial fibrillation. For those
The skeptical cardiologist is a firm believer in the benefit of maintaining normal rhythm in most patients who develop atrial fibrillation (AF, see here.) Sometimes this can be accomplished by
While surveying his garden this morning the skeptical cardiologist felt the cockles of his heart warm when he viewed the budding plant below: The plant I beheld was the glorious,
Anthony C. Pearson M.D., F.A.C.C. is a cardiologist, musician, writer and a regular columnist at MedPage Today